Osteoradionecrosis (ORN) of the jaw is a significant complication of radiotherapy for oral cavity cancer. In addition to antibiotic medication, treatment options such as hyperbaric oxygen therapy, surgical approaches, and combined therapy with pentoxifylline and tocopherol have been recently introduced. In this review article, we will discuss the definition and classifications of osteoradionecrosis, its etiology and pathophysiology, previous treatment options, oral and maxillofacial complications of radiotherapy, basic information on pentoxifylline and tocopherol, recent reports of pentoxifylline and tocopherol combined therapy, and, finally, ORN-induced animal models and future approaches.
CITATION STYLE
Fan, H., Kim, S. M., Cho, Y. J., Eo, M. Y., Lee, S. K., & Woo, K. M. (2014). New approach for the treatment of osteoradionecrosis with pentoxifylline and tocopherol. Biomaterials Research. BioMed Central Ltd. https://doi.org/10.1186/2055-7124-18-13
Mendeley helps you to discover research relevant for your work.